全部文章
Semaglutide Tracker: What to Track (Ozempic, Wegovy, Rybelsus)
A semaglutide tracker logs your dose, injection site or pill timing, weight trend, protein & side effects across Ozempic, Wegovy & Rybelsus. Here's what to track.
Shotsy Alternative for GLP-1 Users: An Honest 2026 Comparison — Havit vs Shotsy
Looking for a Shotsy alternative on Ozempic or Zepbound? What Shotsy's shot tracker does well, where it stops, and how an all-in-one GLP-1 app compares.
Tirzepatide Side Effects: Mounjaro & Zepbound (2026)
The most common tirzepatide side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying, which need urgent medical care.
Tirzepatide Tracker: What to Track on Mounjaro & Zepbound
A tirzepatide tracker logs your weekly dose, injection site, weight trend, protein & side effects — for Mounjaro or Zepbound. Learn what to track and why.
Wegovy Side Effects: Nausea, Hair Loss & Timeline (2026)
Wegovy's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Because Wegovy titrates to a higher 2.4 mg dose, these are reported more often than with Ozempic. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying.
Wegovy Tracker: What to Track on Wegovy & How (2026)
A Wegovy tracker logs your dose date, injection site, weight trend, protein & side effects. Learn exactly what to track on semaglutide and why it matters.
WeightWatchers GLP-1 Alternative: An Honest 2026 Comparison — Havit vs WeightWatchers
Looking for a WeightWatchers GLP-1 alternative? What WW's Points program and WeightWatchers Clinic do well, where they leave gaps, and how to choose a tracker.
Zepbound Side Effects: Nausea, Hair Loss & Timeline (2026)
Zepbound's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Injection-site reactions and hair loss are also labeled. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying, which need urgent care.
Zepbound Tracker: What to Track on Zepbound & How (2026)
A Zepbound tracker logs your dose date, injection site, weight trend, protein & side effects. Learn exactly what to track on tirzepatide and why it matters.
单用GLP-1不够——WHO/ADA推荐的"药物+行为疗法"模式,以及HAVIT的M0/M1/M2阶段
GLP-1受体激动剂(Wegovy、Mounjaro、Zepbound)可产生15-22%的平均减重(STEP 1、SURMOUNT-1)。但STEP 4报告停药一年后体重反弹+11.6%p——约78%的减重量返回。WHO(2022)和ADA Standards(2024)明确推荐在药物治疗同时进行行为疗法,STEP 3(JAMA 2021)显示强化行为疗法联合用药的减重效果是标准护理联合用药的近3倍(−16% vs −5.7%)。HAVIT将此结构化为3个阶段——用药前(M0)、适应期(M1)、维持/停药期(M2)——整合药物、肌肉保护和行为学习。HAVIT不开具GLP-1处方;处方、剂量和停药决策仍属医生职责范围。
让身体成分检测普及化——HAVIT 基于问卷的模型如何达到临床工具级准确度(n=70 内部对比研究,以 InBody 为参照)
有效的肥胖和代谢健康管理始于准确的身体成分基线。标准工具(DEXA、InBody)存在三重门槛——设备昂贵、需到场检测、单次费用高。HAVIT 仅通过智能手机问卷+基础身体信息(身高、体重、性别、年龄)即可估算体脂率、肌肉量、内脏脂肪、基础代谢率、总能量消耗、腰高比和生理年龄。n=70 内部对比 vs InBody:±5% 一致率 92.9%,MAE 2.42%p,CCC 0.93,在 6 项指标上统计学显著优于 Deurenberg 标准公式(Steiger Z p=0.030)。目标是让身体成分检测普及化用于非临床日常追踪——任何人、任何地点、任何时间,无需额外设备。HAVIT 不是医疗诊断工具。
数字健康教练的新标准——HAVIT 8步AI教练引擎如何整合个性化、即时反馈与行为触发
大多数健康应用提供的是静态处方,如'今天摄入1,500千卡'。但文献表明,数字行为干预的有效性与个性化·反馈即时性·行为触发的整合程度成正比(Tate 2003 JAMA; Patel 2015 Ann Intern Med)。HAVIT的8步教练引擎基于Fogg行为模型(B = M × A × P)和自我决定理论(自主性·胜任感·关系),将126种原型 × 2,000+行为库中的处方与每时每刻变化的用户信号相匹配。HAVIT不是医疗诊断工具;临床诊断和治疗决策属于医生的专业领域。
